$474 Million is the total value of Virtus ETF Advisers LLC's 434 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 27.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARRY | Sell | ARRAY BIOPHARMA INC | $1,267,000 | +6.2% | 27,357 | -44.1% | 0.27% | -89.5% |
RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $899,000 | -20.9% | 14,162 | -13.6% | 0.19% | -92.1% |
FOLD | Sell | AMICUS THERAPEUTICS INC | $890,000 | -11.2% | 71,320 | -3.2% | 0.19% | -91.2% |
INCY | Sell | INCYTE CORP | $885,000 | -10.6% | 10,417 | -9.5% | 0.19% | -91.1% |
MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $841,000 | -16.5% | 67,570 | -2.5% | 0.18% | -91.7% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $814,000 | -13.4% | 9,646 | -9.6% | 0.17% | -91.4% |
ENTA | Sell | ENANTA PHARMACEUTICALS INC | $796,000 | -21.7% | 9,433 | -11.3% | 0.17% | -92.2% |
RARX | Sell | RA PHARMACEUTICALS INC | $377,000 | +3.9% | 12,543 | -22.5% | 0.08% | -89.8% |
APLS | Sell | APELLIS PHARMACEUTICALS INC | $319,000 | +13.9% | 12,600 | -12.1% | 0.07% | -88.8% |
TGTX | Sell | TG THERAPEUTICS INC | $318,000 | -26.7% | 36,741 | -31.9% | 0.07% | -92.7% |
CYTK | Sell | CYTOKINETICS INC | $315,000 | +15.4% | 27,962 | -17.2% | 0.07% | -88.6% |
TCDA | Sell | TRICIDA INC | $306,000 | -8.1% | 7,762 | -10.0% | 0.06% | -90.8% |
RETA | Sell | REATA PHARMACEUTICALS INCcl a | $309,000 | -17.8% | 3,273 | -25.5% | 0.06% | -91.9% |
FATE | Sell | FATE THERAPEUTICS INC | $304,000 | +4.1% | 14,965 | -9.9% | 0.06% | -89.7% |
VYGR | Sell | VOYAGER THERAPEUTICS INC | $300,000 | -38.9% | 11,011 | -57.1% | 0.06% | -94.0% |
PTCT | Sell | PTC THERAPEUTICS INC | $300,000 | +0.3% | 6,660 | -16.2% | 0.06% | -90.1% |
ZIOP | Sell | ZIOPHARM ONCOLOGY INC | $298,000 | -16.1% | 51,100 | -44.5% | 0.06% | -91.7% |
ATNX | Sell | ATHENEX INC | $297,000 | +12.9% | 14,984 | -30.2% | 0.06% | -88.8% |
AGEN | Sell | AGENUS INC | $301,000 | -5.6% | 100,271 | -6.7% | 0.06% | -90.7% |
FGEN | Sell | FIBROGEN INC | $297,000 | -20.2% | 6,565 | -4.0% | 0.06% | -92.0% |
MRTX | Sell | MIRATI THERAPEUTICS INC | $292,000 | -38.8% | 2,839 | -56.4% | 0.06% | -93.9% |
QURE | Sell | UNIQURE NV | $287,000 | -49.6% | 3,670 | -61.5% | 0.06% | -95.0% |
BLUE | Sell | BLUEBIRD BIO INC | $289,000 | -30.4% | 2,274 | -13.7% | 0.06% | -93.1% |
EPZM | Sell | EPIZYME INC | $288,000 | -48.8% | 22,930 | -49.6% | 0.06% | -94.9% |
RGNX | Sell | REGENXBIO INC | $284,000 | -15.2% | 5,524 | -5.4% | 0.06% | -91.6% |
GLYC | Sell | GLYCOMIMETICS INC | $284,000 | -14.2% | 23,838 | -10.2% | 0.06% | -91.5% |
KURA | Sell | KURA ONCOLOGY INC | $282,000 | -12.7% | 14,322 | -26.3% | 0.06% | -91.4% |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $278,000 | -26.8% | 2,951 | -37.8% | 0.06% | -92.7% |
ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $274,000 | -17.7% | 10,330 | -43.0% | 0.06% | -91.8% |
CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $270,000 | -4.3% | 38,935 | -4.2% | 0.06% | -90.5% |
BOLD | Sell | AUDENTES THERAPEUTICS INC | $267,000 | -41.6% | 7,053 | -39.8% | 0.06% | -94.2% |
EIDX | Sell | EIDOS THERAPEUTICS INC | $264,000 | -36.1% | 8,495 | -51.7% | 0.06% | -93.6% |
GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $260,000 | -22.6% | 4,938 | -22.1% | 0.06% | -92.3% |
PRNB | Sell | PRINCIPIA BIOPHARMA INC | $256,000 | -16.9% | 7,700 | -14.9% | 0.05% | -91.8% |
ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $255,000 | -49.0% | 2,214 | -47.9% | 0.05% | -94.9% |
ESPR | Sell | ESPERION THERAPEUTICS INC NE | $253,000 | +15.0% | 5,430 | -1.0% | 0.05% | -88.7% |
RCKT | Sell | ROCKET PHARMACEUTICALS INC | $248,000 | -20.5% | 16,535 | -7.1% | 0.05% | -92.2% |
SRNE | Sell | SORRENTO THERAPEUTICS INC | $226,000 | -55.9% | 84,682 | -21.4% | 0.05% | -95.6% |
BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $186,000 | -51.2% | 4,249 | -42.7% | 0.04% | -95.2% |
HDB | Sell | HDFC BANK LTDsponsored ads | $79,000 | -14.1% | 604 | -24.3% | 0.02% | -91.3% |
IBN | Sell | ICICI BK LTDadr | $40,000 | -16.7% | 3,178 | -24.3% | 0.01% | -92.2% |
PBRA | Sell | PETROLEO BRASILEIRO SA PETROsp adr non vtg | $32,000 | -41.8% | 2,246 | -41.9% | 0.01% | -94.0% |
CSGP | Sell | COSTAR GROUP INC | $33,000 | +3.1% | 59 | -13.2% | 0.01% | -89.7% |
NTES | Sell | NETEASE INCsponsored adr | $23,000 | +4.5% | 91 | -1.1% | 0.01% | -89.4% |
NEE | Sell | NEXTERA ENERGY INC | $23,000 | -14.8% | 113 | -19.9% | 0.01% | -91.2% |
HTHT | Sell | HUAZHU GROUP LTDsponsored ads | $24,000 | -17.2% | 671 | -1.9% | 0.01% | -91.9% |
XEL | Sell | XCEL ENERGY INC | $24,000 | -36.8% | 409 | -39.9% | 0.01% | -93.8% |
PSA | Sell | PUBLIC STORAGE | $19,000 | -13.6% | 80 | -21.6% | 0.00% | -91.5% |
EQR | Sell | EQUITY RESIDENTIALsh ben int | $19,000 | -32.1% | 253 | -31.8% | 0.00% | -93.3% |
WEC | Sell | WEC ENERGY GROUP INC | $20,000 | -44.4% | 240 | -46.8% | 0.00% | -94.8% |
ABEV | Sell | AMBEV SAsponsored adr | $20,000 | -37.5% | 4,305 | -41.5% | 0.00% | -94.1% |
YUMC | Sell | YUM CHINA HLDGS INC | $12,000 | 0.0% | 262 | -5.8% | 0.00% | -88.5% |
CHRW | Sell | C H ROBINSON WORLDWIDE INC | $12,000 | -33.3% | 144 | -29.4% | 0.00% | -92.1% |
ERJ | Sell | EMBRAER S Asponsored ads | $3,000 | -40.0% | 170 | -40.1% | 0.00% | -90.9% |
WDAY | Exit | WORKDAY INCcl a | $0 | – | -80 | -100.0% | -0.03% | – |
AAP | Exit | ADVANCE AUTO PARTS INC | $0 | – | -92 | -100.0% | -0.03% | – |
EWBC | Exit | EAST WEST BANCORP INC | $0 | – | -339 | -100.0% | -0.03% | – |
IVZ | Exit | INVESCO LTD | $0 | – | -952 | -100.0% | -0.04% | – |
ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -32 | -100.0% | -0.04% | – |
APTX | Exit | APTINYX INC | $0 | – | -12,427 | -100.0% | -0.11% | – |
FB | Exit | FACEBOOK INCcl a | $0 | – | -435 | -100.0% | -0.16% | – |
CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -7,934 | -100.0% | -0.38% | – |
INO | Exit | INOVIO PHARMACEUTICALS INC | $0 | – | -52,943 | -100.0% | -0.42% | – |
STIM | Exit | NEURONETICS INC | $0 | – | -13,535 | -100.0% | -0.44% | – |
KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -11,763 | -100.0% | -0.45% | – |
ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -50,655 | -100.0% | -0.46% | – |
MRKR | Exit | MARKER THERAPEUTICS INC | $0 | – | -39,672 | -100.0% | -0.56% | – |
KDMN | Exit | KADMON HLDGS INC | $0 | – | -119,987 | -100.0% | -0.67% | – |
ASRT | Exit | ASSERTIO THERAPEUTICS INC | $0 | – | -64,315 | -100.0% | -0.69% | – |
OPTN | Exit | OPTINOSE INC | $0 | – | -34,499 | -100.0% | -0.76% | – |
FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -27,492 | -100.0% | -0.78% | – |
NITE | Exit | NIGHTSTAR THERAPEUTICS PLCadr | $0 | – | -23,777 | -100.0% | -1.28% | – |
ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -48,468 | -100.0% | -1.37% | – |
ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -19,751 | -100.0% | -4.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERTEX PHARMACEUTICALS INC | 34 | Q2 2024 | 1.7% |
REGENERON PHARMACEUTICALS | 34 | Q2 2024 | 1.8% |
INCYTE CORP | 34 | Q2 2024 | 2.1% |
EXELIXIS INC | 34 | Q2 2024 | 1.8% |
IRONWOOD PHARMACEUTICALS INC | 34 | Q2 2024 | 2.0% |
LIGAND PHARMACEUTICALS INC | 34 | Q2 2024 | 1.5% |
HALOZYME THERAPEUTICS INC | 34 | Q2 2024 | 1.7% |
GILEAD SCIENCES INC | 34 | Q2 2024 | 1.6% |
UNITED THERAPEUTICS CORP DEL | 34 | Q2 2024 | 1.8% |
IONIS PHARMACEUTICALS INC | 34 | Q2 2024 | 1.8% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-28 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-15 |
13F-HR | 2023-11-07 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.